We begin clinical trial recruitment in the UK
We have announced that the first patient in the UK has been enrolled to the CIBIL clinical trial !Read more
We obtain CE marking for our APILIFE solution
We, as a start-up specializing in predictive medicine devices, has obtained Class IIa CE marking for its Apilife solutionRead more
We announced the first patient enrolled in our clinical trial !
This marks the beginning of this first-of-its-kind clinical trial conducted in Europe evaluating a digital health solution.Read more
French start-up Cibiltech receives CE mark
The CE marking allows the company to market its medical device in all countries that recognize this certification...Read more